+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Analgesics Market by Type, by Route of Administration, - Global Opportunity Analysis and Industry Forecast, 2020-2030

  • ID: 5206332
  • Report
  • August 2020
  • Region: Global
  • 246 pages
  • Next Move Strategy Consulting

FEATURED COMPANIES

  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Endo Pharmaceuticals
  • GlaxoSmithKline PLC
  • Johnson & Johnson
Market Definition:

The Global Analgesics Market was valued at USD 25.44 billion in 2019 and is projected to reach USD 29.58 billion by 2030, expanding at a CAGR of 1.30% during the forecast period, from 2020 to 2030.

Analgesics, also known as pain killers, are used to treat various types of pain caused by wounds, surgeries, ailment, and illnesses, among others. Various opioids, non-opioids and combination drugs are used for pain management. Opioid drugs are a type of painkillers derived from opium and are used to treat moderate to severe pain.

Market Dynamics and Trends

Increasing incidences of various acute and chronic disorders, growth of the geriatric population, and rising prevalence of cardiovascular disorders, arthritis, and other ailments are driving the analgesics market growth. Also, increasing sales of over the counter drugs, rise in the demand for pain management due to the changing lifestyle, poor eating habits and posture, growing prevalence of obesity are contributing to the growth of the market.

However, stringent regulatory policies regarding drug abuse are expected to hinder the market growth. Conversely, rise in the R&D activities has led to the development of innovative drugs and increased the demand for personalized medicines, thus creating new opportunities in the analgesics market.

Market Segmentations and Scope of the Study:

The global analgesics market has been segmeneted on the basis of type, route of administration, and geography. Based on type, the market is bifurcated into non-opioids and opioids. In terms of route of administration, the market is segregated into oral, intravenous, rectal, transdermal, and tropical. On the basis of geography, the market is fragmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Geographical Analysis

North America hols the major share of the market and this trend is projected to continue during the forecast period due to the increasing prevalence of chronic disorders, rise in the demand for pain management, and growth in R&D activities.

The market in Asia Pacific is expected to grow in the coming years owing to the presence of developing economies, increase in the prevalence of chronic disorders, rise in geriatric population, and growth in the need for OTC drugs.

Competitive Landscape

Key players in the global analgesics market include Novartis AG, GlaxoSmithKline PLC, Bayer AG, Johnson & Johnson, Pfizer Inc., Endo Pharmaceuticals, Reckitt Benckiser (RB), Eli Lilly and Company, Bristol-Myers Squibb, and Sanofi S.A.

KEY MARKET SEGMENTS:

Global Analgesics Market - By Type
  • Non-opioids
  • Opioids
Global Analgesics Market - By Route of Administration
  • Oral
  • Intravenous
  • Rectal
  • Transdermal
  • Tropical
Global Analgesics Market - By Geography
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • U.K.
  • Germany
  • Spain
  • Sweden
  • France
  • Russia
  • Denmark
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Indonesia
  • Rest of Asia-Pacific
  • RoW
  • UAE
  • Brazil
  • Venezuela
  • Chile
  • Saudi Arabia
  • Morocco
  • Kenya
  • Nigeria
  • Remaining Countries
KEY PLAYERS:
  • Novartis AG
  • GlaxoSmithKline PLC
  • Bayer AG
  • Johnson & Johnson
  • Pfizer Inc.
  • Endo Pharmaceuticals
  • Reckitt Benckiser (RB)
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Sanofi S.A.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Endo Pharmaceuticals
  • GlaxoSmithKline PLC
  • Johnson & Johnson
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1 Secondary Research
1.2.2 Data Analysis Framework
1.2.3 Market Size Estimation
1.2.4 Forecasting
1.2.5 Primary Research and Data Validation

2. Market Snapshot, 2019-2030 Million Usd
2.1. Market Snapshot

3. Porter's Five Force Model Analysis

4. Market Dynamics
4.1. Growth Drivers
4.1.1 Driver 1
4.1.2 Driver 2
4.1.3 Driver 3
4.1.4 Driver 4
4.2. Challenges
4.2.1 Challenge 1
4.2.2 Challenge 2
4.3. Opportunities
4.3.1 Opportunity 1
4.3.2 Opportunity 2

5. Global Analgesics Market, by Type
5.1. Overview
5.2. Non-Opiods
5.2.1 Non-Opiods Market, by Region
5.2.1.1 North America Non-Opiods Market, by Country
5.2.1.2 Europe Non-Opiods Market, by Country
5.2.1.3 Asia-Pacific Non-Opiods Market, by Country
5.2.1.4 Rest of World Non-Opiods Market, by Country
5.3. Opiods
5.3.1 Opiods Market, by Region
5.3.1.1 North America Opiods Market, by Country
5.3.1.2 Europe Opiods Market, by Country
5.3.1.3 Asia-Pacific Opiods Market, by Country
5.3.1.4 Rest of World Opiods Market, by Country

6. Global Analgesics Market, by Route of Administration
6.1. Overview
6.2. Oral Route
6.2.1 Oral Route Market, by Region
6.2.1.1 North America Oral Route Market, by Country
6.2.1.2 Europe Oral Route Market, by Country
6.2.1.3 Asia-Pacific Oral Route Market, by Country
6.2.1.4 Rest of World Oral Route Market, by Country
6.3. Intravenous Route
6.3.1 Intravenous Route Market, by Region
6.3.1.1 North America Intravenous Route Market, by Country
6.3.1.2 Europe Intravenous Route Market, by Country
6.3.1.3 Asia-Pacific Intravenous Route Market, by Country
6.3.1.4 Rest of World Intravenous Route Market, by Country
6.4. Rectal Route
6.4.1 Rectal Route Market, by Region
6.4.1.1 North America Rectal Route Market, by Country
6.4.1.2 Europe Rectal Route Market, by Country
6.4.1.3 Asia-Pacific Rectal Route Market, by Country
6.4.1.4 Rest of World Rectal Route Market, by Country
6.5. Transdermal Route
6.5.1 Transdermal Route Market, by Region
6.5.1.1 North America Transdermal Route Market, by Country
6.5.1.2 Europe Transdermal Route Market, by Country
6.5.1.3 Asia-Pacific Transdermal Route Market, by Country
6.5.1.4 Rest of World Transdermal Route Market, by Country
6.6. Tropical Route
6.6.1 Tropical Route Market, by Region
6.6.1.1 North America Tropical Route Market, by Country
6.6.1.2 Europe Tropical Route Market, by Country
6.6.1.3 Asia-Pacific Tropical Route Market, by Country
6.6.1.4 Rest of World Tropical Route Market, by Country

7. Global Analgesics Market, by Region
7.1. Overview
7.2. North America
7.2.1 North America Analgesics Market, by Type
7.2.2 North America Analgesics Market, by Route of Administration
7.2.3 North America Analgesics, Market by Country
7.2.3.1 U.S
7.2.3.1.1 U.S Analgesics Market, by Type
7.2.3.1.2 U.S Analgesics Market, by Route of Administration
7.2.3.2 Canada
7.2.3.2.1 Canada Analgesics Market, by Type
7.2.3.2.2 Canada Analgesics Market, by Route of Administration
7.2.3.3 Mexico
7.2.3.3.1 Mexico Analgesics Market, by Type
7.2.3.3.2 Mexico Analgesics Market, by Route of Administration
7.3. Europe
7.3.1 Europe Analgesics Market, by Type
7.3.2 Europe Analgesics Market, by Route of Administration
7.3.3 Europe Analgesics, Market by Country
7.3.3.1 United Kingdom
7.3.3.1.1 United Kingdom Analgesics Market, by Type
7.3.3.1.2 United Kingdom Analgesics Market, by Route of Administration
7.3.3.2 Germany
7.3.3.2.1 Germany Analgesics Market, by Type
7.3.3.2.2 Germany Analgesics Market, by Route of Administration
7.3.3.3 France
7.3.3.3.1 France Analgesics Market, by Type
7.3.3.3.2 France Analgesics Market, by Route of Administration
7.3.3.4 Spain
7.3.3.4.1 Spain Analgesics Market, by Type
7.3.3.4.2 Spain Analgesics Market, by Route of Administration
7.3.3.5 Denmark
7.3.3.5.1 Denmark Analgesics Market, by Type
7.3.3.5.2 Denmark Analgesics Market, by Route of Administration
7.3.3.6 Sweden
7.3.3.6.1 Sweden Analgesics Market, by Type
7.3.3.6.2 Sweden Analgesics Market, by Route of Administration
7.3.3.7 Russia
7.3.3.7.1 Russia Analgesics Market, by Type
7.3.3.7.2 Russia Analgesics Market, by Route of Administration
7.3.3.8 Rest of Europe
7.3.3.8.1 Rest of Europe Analgesics Market, by Type
7.3.3.8.2 Rest of Europe Analgesics Market, by Route of Administration
7.4. Asia-Pacific
7.4.1 Asia-Pacific Analgesics Market, by Type
7.4.2 Asia-Pacific Analgesics Market, by Route of Administration
7.4.3 Asia-Pacific Analgesics, Market by Country
7.4.3.1 Japan
7.4.3.1.1 Japan Analgesics Market, by Type
7.4.3.1.2 Japan Analgesics Market, by Route of Administration
7.4.3.2 China
7.4.3.2.1 China Analgesics Market, by Type
7.4.3.2.2 China Analgesics Market, by Route of Administration
7.4.3.3 India
7.4.3.3.1 India Analgesics Market, by Type
7.4.3.3.2 India Analgesics Market, by Route of Administration
7.4.3.4 Australia
7.4.3.4.1 Australia Analgesics Market, by Type
7.4.3.4.2 Australia Analgesics Market, by Route of Administration
7.4.3.5 Indonesia
7.4.3.5.1 Indonesia Analgesics Market, by Type
7.4.3.5.2 Indonesia Analgesics Market, by Route of Administration
7.4.3.6 Rest of Asia-Pacific
7.4.3.6.1 Rest of Asia-Pacific Analgesics Market, by Type
7.4.3.6.2 Rest of Asia-Pacific Analgesics Market, by Route of Administration
7.5. Rest of World
7.5.1 Rest of World Analgesics Market, by Type
7.5.2 Rest of World Analgesics Market, by Route of Administration
7.5.3 Rest of World Analgesics, Market by Country
7.5.3.1 Brazil
7.5.3.1.1 Brazil Analgesics Market, by Type
7.5.3.1.2 Brazil Analgesics Market, by Route of Administration
7.5.3.2 Venezuela
7.5.3.2.1 Venezuela Analgesics Market, by Type
7.5.3.2.2 Venezuela Analgesics Market, by Route of Administration
7.5.3.3 Chile
7.5.3.3.1 Chile Analgesics Market, by Type
7.5.3.3.2 Chile Analgesics Market, by Route of Administration
7.5.3.4 Saudi Arabia
7.5.3.4.1 Saudi Arabia Analgesics Market, by Type
7.5.3.4.2 Saudi Arabia Analgesics Market, by Route of Administration
7.5.3.5 Uae
7.5.3.5.1 Uae Analgesics Market, by Type
7.5.3.5.2 Uae Analgesics Market, by Route of Administration
7.5.3.6 Morocco
7.5.3.6.1 Morocco Analgesics Market, by Type
7.5.3.6.2 Morocco Analgesics Market, by Route of Administration
7.5.3.7 Kenya
7.5.3.7.1 Kenya Analgesics Market, by Type
7.5.3.7.2 Kenya Analgesics Market, by Route of Administration
7.5.3.8 Nigeria
7.5.3.8.1 Nigeria Analgesics Market, by Type
7.5.3.8.2 Nigeria Analgesics Market, by Route of Administration
7.5.3.9 Remaining Countries
7.5.3.9.1 Remaining Countries Analgesics Market, by Type
7.5.3.9.2 Remaining Countries Analgesics Market, by Route of Administration

8. Company Profiles
8.1. Bayer AG
8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4 Product Portfolio
8.1.5 Business Performance
8.1.6 Key Strategic Moves and Development
8.2. Novartis AG
8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4 Product Portfolio
8.2.5 Business Performance
8.2.6 Key Strategic Moves and Development
8.3. GlaxoSmithKline plc
8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4 Product Portfolio
8.3.5 Business Performance
8.3.6 Key Strategic Moves and Development
8.4. Pfizer Inc.
8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4 Product Portfolio
8.4.5 Business Performance
8.4.6 Key Strategic Moves and Development
8.5. Johnson & Johnson
8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4 Product Portfolio
8.5.5 Business Performance
8.5.6 Key Strategic Moves and Development
8.6. Reckitt Benckiser
8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4 Product Portfolio
8.6.5 Business Performance
8.6.6 Key Strategic Moves and Development
8.7. Endo Pharmaceuticals
8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4 Product Portfolio
8.7.5 Business Performance
8.7.6 Key Strategic Moves and Development
8.8. Bristol-Myers Squbb
8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.4 Product Portfolio
8.8.5 Business Performance
8.8.6 Key Strategic Moves and Development
8.9. Eli Lilly and Company
8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4 Product Portfolio
8.9.5 Business Performance
8.9.6 Key Strategic Moves and Development
8.10. Sanofi
8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4 Product Portfolio
8.10.5 Business Performance
8.10.6 Key Strategic Moves and Development
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Endo Pharmaceuticals
  • GlaxoSmithKline PLC
  • Johnson & Johnson
Analgesics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2030-Rising prevalence of acute and chronic disorders such as cancer, cardiovascular disorders, and arthritis are driving the Global Analgesics Market.

Analgesics or pain killers are used for the treatment of different types of pain caused by diseases, illness, and wounds. Analgesics consist of different types of opioids, non-opioids and combination drugs for effective pain management.

The global analgesics market has been segmented on the basis of type, route of administration, and geography. Based on type, the market is bifurcated into non-opioids and opioids. In terms of route of administration, the market is segregated into oral, intravenous, rectal, transdermal, and tropical. On the basis of geography, the market is fragmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Note: Product cover images may vary from those shown
  • Novartis AG
  • GlaxoSmithKline PLC
  • Bayer AG
  • Johnson & Johnson
  • Pfizer Inc.
  • Endo Pharmaceuticals
  • Reckitt Benckiser (RB)
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Sanofi S.A
Note: Product cover images may vary from those shown
Adroll
adroll